Alpha Cubed Investments’s Myriad Genetics MYGN Stock Holding History

Alpha Cubed Investments’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,950	Closed	-$338K	–	198
2015 Q2	$338K	Hold	9,950	–	–	0.09%	141
2015 Q1	$352K	Sell	9,950 -1,950	-16%	-$69.8K	0.11%	132
2014 Q4	$405K	Sell	11,900 -1,300	-10%	-$46.1K	0.16%	106
2014 Q3	$509K	Sell	13,200 -300	-2%	-$11.2K	0.24%	101
2014 Q2	$525K	Sell	13,500 -900	-6%	-$33.5K	0.23%	113
2014 Q1	$492K	Sell	14,400 -22,800	-61%	-$706K	0.26%	111
2013 Q4	$780K	Buy	+37,200	New	+$941K	0.28%	117

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha Cubed Investments's MYGN Position: Q3 2015 in Review

Alpha Cubed Investments sold out of Myriad Genetics (MYGN) in Q3 2015, closing a stake of 9,950 shares — an estimated $338K sold.

Alpha Cubed Investments first reported a position in MYGN in Q4 2013 and held it in 7 quarters. The position peaked at $780K in Q4 2013. 234 funds tracked by Wall St. Rank hold MYGN as of Q3 2015.

Alpha Cubed Investments reported no remaining Myriad Genetics position as of Q3 2015 after selling out during the quarter.
Alpha Cubed Investments sold 9,950 Myriad Genetics shares in Q3 2015, an estimated $338K.
Alpha Cubed Investments first reported a position in Myriad Genetics in Q4 2013 and held it in 7 quarters.
Alpha Cubed Investments's Myriad Genetics position peaked at $780K in Q4 2013.
234 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2015.

Based on Alpha Cubed Investments's 13F filing for Q3 2015, filed 9 Nov 2015.